Retinal Ganglion Cell Dysfunction in Asymptomatic G11778A: Leber Hereditary Optic Neuropathy
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
PURPOSE: To report the serial evaluation of asymptomatic eyes of subjects with mutated G11778A mitochondrial DNA. METHODS: Forty-five asymptomatic G11778A Leber hereditary optic neuropathy (LHON) carriers and two patients with the mutation who developed unilateral visual loss underwent testing that included visual acuity, automated visual field, pattern electroretinogram (PERG), and spectral-domain optical coherence tomography every 6 months between September 2008 and March 2012. RESULTS: Visual acuity, visual fields, and retinal nerve fiber layer thickness remained stable within the normal range. Mean PERG amplitudes of carriers dropped progressively by ∼ 40% from baseline to 36 months. In addition, comparisons with the fellow eyes of patients with unilateral optic neuritis revealed a 3.4 ETDRS (Early Treatment Diabetic Retinopathy Study) letter loss in the LHON carriers. A single carrier developed visual loss, with PERG amplitudes dropping by half. In one of two LHON cases who presented with unilateral visual loss, visual acuity in the asymptomatic eye was ∼ 20/40 at baseline. The PERG amplitude of this eye was reduced to ∼ 30% of normal. Six months later, his visual acuity had dropped to ∼ 20/500. A second patient who was ∼ 20/20 and had a visual field defect in the asymptomatic eye at baseline remained at this level for the 18 months of follow-up. His PERG amplitudes were similar to those of asymptomatic carriers, with 0.78 μV at baseline that did not decline with follow-up. CONCLUSIONS: Declines of the PERG amplitude suggest subclinical retinal ganglion cell dysfunction in asymptomatic G11778A subjects, which is progressive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy
Wallace, D. C., Singh, G., Lott, M. T., Hodge, J. A., Schurr, T. G., Lezza, A. M. S., Elsas, L. J., & Nikoskelainen, E. K. (1988) · Science · doi:10.1126/science.3201231 · Cited by 2,440
Mitochondrial optic neuropathies—Disease mechanisms and therapeutic strategies
Yu-Wai-Man, P., Griffiths, P. G., & Chinnery, P. F. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.11.002 · Cited by 633 · cited 1×
“Leber hereditary optic neuropathy (LHON) is a maternally inherited mitochondrial genetic disease characterized by severe visual loss.(1) The clinical findings were first described in 1871 by Theodore Leber.”
BackgroundA randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy.
Klopstock, T., Yu-Wai-Man, P., Dimitriadis, K., Rouleau, J., Heck, S., Bailie, M., Atawan, A., Chattopadhyay, S., Schubert, M., Garip, A., et al. (2011) · Brain · doi:10.1093/brain/awr170 · Cited by 578
Newman, N. J., Lott, M. T., & Wallace, D. C. (1991) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)76784-4 · Cited by 403 · cited 1×
“Affected individuals are usually entirely asymptomatic until they develop visual blurring affecting the central visual field.(4) Onset of visual loss initially may be simultaneous in both eyes or in just one eye.”
Background
Cited by
Gene Therapy for Leber Hereditary Optic Neuropathy
Feuer, W. J., Schiffman, J. C., Davis, J. L., Porciatti, V., Gonzalez, P., Koilkonda, R. D., Yuan, H., Lalwani, A., Lam, B. L., & Guy, J. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2015.10.025 · Cited by 230
“There is no predictive test to determine who is at risk for vision loss.(10)”
BackgroundSelf-citationLeber hereditary optic neuropathy: current perspectives.
McClelland, C., Meyerson, C., & Van Stavern, G. (2015) · Clinical Ophthalmology · doi:10.2147/opth.s62021 · Cited by 196
“ERG in asymptomatic LHON mutation carriers showed a significant decline in N95 amplitude by ~40% from baseline over 36 months, suggesting that subclinical RGC loss is progressive in unaffected carriers and precedes the onset of visual field defects.(36) Pattern ERG may therefore be a useful tool to monitor subclinical…”
Newman, N. J., Yu-Wai-Man, P., Carelli, V., Biousse, V., Moster, M. L., Vignal-Clermont, C., Sergott, R. C., Klopstock, T., Sadun, A. A., Girmens, J.-F., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.662838 · Cited by 64
Vignal-Clermont, C., Girmens, J.-F., Audo, I., Said, S. M., Errera, M.-H., Plaine, L., O’Shaughnessy, D., Taiel, M., & Sahel, J.-A. (2021) · BioDrugs · doi:10.1007/s40259-021-00468-9 · Cited by 51
“Subjects with ND4 LHON who are simply carriers of the 11778-ND4 mutation present a normal BCVA before the expression of the disease, and it has been shown that these non-affected patients with (asymptomatic) LHON (ND4 mutation carriers only) have a preserved BCVA (LogMAR 0; Snellen 20/20) [27, 28].”
BackgroundMoster, S. J., Moster, M. L., Scannell Bryan, M., & Sergott, R. C. (2016) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.15-17328 · Cited by 47
“Center 13 (12, 15) 14 (7, 16) 12 (9, 14) 9 (7, 10)* 9 (8, 11)* 8 (7, 9)* Nasal inner 53 (46, 55) 42 (26, 56) 31 (24, 37)* 20 (15, 24)* 22 (19, 28)* 20 (18, 26)* Nasal outer 39 (36, 43) 33 (24, 43) 30 (26, 34)* 24 (21, 27)* 25 (23, 27)* 23 (21, 25)* Superior inner 55 (49, 58) 48 (35, 56) 36 (29, 44)* 24 (19, 30)* 26 (2…”
Metadata
- Authors
- Guy, J., Feuer, W. J., Porciatti, V., Schiffman, J., Abukhalil, F., Vandenbroucke, R., Rosa, P. R., & Lam, B. L.
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2014-02-10
- Volume
- 55
- Issue
- 2
- Pages
- 841
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W1987694121
- Cited by
- 54
- References
- 4
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Retinal Ganglion Cell Dysfunction in Asymptomatic G11778A: Leber Hereditary Optic Neuropathy. https://app.cochat.ai/papers/10.1167/iovs.13-13365
- The paper
- Guy, J., Feuer, W. J., Porciatti, V., Schiffman, J., Abukhalil, F., Vandenbroucke, R., Rosa, P. R., & Lam, B. L. (2014). Retinal Ganglion Cell Dysfunction in Asymptomatic G11778A: Leber Hereditary Optic Neuropathy. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.13-13365
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.